Description
SLU-PP-332 is a small-molecule compound investigated in vitro as a PPARδ/β agonist with potential applications in metabolic and performance research. Early studies have explored its role in enhancing endurance, promoting lipid metabolism, improving mitochondrial function, and supporting energy expenditure. This oral tablet format delivers 500mcg per unit, provided in a 100-count bottle for consistent dosing in extended laboratory study protocols.



S. Patel –
Fantastic compound! Boosts endurance, supports metabolism, and enhances energy expenditure. Highly recommend it.